Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Families02:47

Protein Families

15.2K
Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
15.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The influence of ligands on AlphaFold3 prediction of cryptic pockets.

Communications biology·2026
Same author

From memorization to generalization: Why physics will improve machine learning -based prediction of protein complexes.

Current opinion in structural biology·2026
Same author

Assessment of Alphafold Protein Models for Small-Molecule Ligand Docking versus Co-Folding.

Journal of chemical information and modeling·2026
Same author

Hierarchical decoding of targeting tripeptide motif by the cytosolic iron-sulfur cluster assembly targeting complex.

bioRxiv : the preprint server for biology·2026
Same author

The scientific legacy of Martin Karplus from the perspective of his collaborators.

Biophysical journal·2026
Same author

A Customizable Antibody Delivery Strategy Using Fc-Affinity Ligands.

ACS biomaterials science & engineering·2026

Related Experiment Video

Updated: May 20, 2025

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

4.9K

E-FTMap: A Protein Structure Based Pharmacophore Identification Server for Guiding Fragment Expansion.

Omeir Khan1, George Jones2, Dima Kozakov3

  • 1Department of Chemistry, Boston University, Boston, MA 02215, United States.

Journal of Molecular Biology
|March 26, 2025
PubMed
Summary

Fragment-based drug design (FBDD) uses E-FTMap to guide the expansion of small molecule fragments into potent drug leads. This automated web server identifies preferred binding regions within protein targets, enhancing drug discovery efficiency.

Keywords:
binding hot spotbinding site characterizationfragment based ligand designprotein mappingwebserver

More Related Videos

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

3.1K
Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
06:29

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Published on: March 3, 2021

5.4K

Related Experiment Videos

Last Updated: May 20, 2025

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

4.9K
NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

3.1K
Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
06:29

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Published on: March 3, 2021

5.4K

Area of Science:

  • Computational chemistry
  • Structural biology
  • Drug discovery

Background:

  • Fragment-based drug design (FBDD) involves screening small compounds that bind weakly to protein targets.
  • Fragment hits require expansion into more potent compounds for higher binding affinities.
  • Ligand binding preferences of target proteins are crucial for guiding fragment expansion strategies.

Purpose of the Study:

  • To introduce E-FTMap, an automated web server for identifying pharmacophore binding regions.
  • To demonstrate E-FTMap's utility in guiding fragment expansion for improved drug potency.
  • To provide a computational tool for structure-based drug design.

Main Methods:

  • E-FTMap distributes 119 small organic probes across a protein's binding site.
  • The server identifies energy minima and clusters probes by atom type to reveal binding preferences.
  • FTMap server can identify binding hot spots if the binding site is not initially known.

Main Results:

  • E-FTMap successfully identified important pharmacophore binding regions for 17 different protein targets.
  • The protocol demonstrated effective guidance for expanding fragment hits into higher affinity binders.
  • The E-FTMap web server provides atom-specific binding information based on protein structure alone.

Conclusions:

  • E-FTMap is a valuable tool for structure-based fragment expansion in drug discovery.
  • The automated protocol enhances the efficiency of developing potent drug leads from fragment hits.
  • E-FTMap facilitates rational drug design by revealing specific ligand-protein interactions.